Consolidated Condensed Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jul. 31, 2013	Jul. 31, 2012
Cash flows from operating activities:
Net income	$ 239,594	$ 176,498
Depreciation and amortization	93,586	80,395
Loss on extinguishment of debt	0	1,404
Decrease in operating capital	(80,902)	(81,700)
Other non-cash items	13,306	23,707
Net cash provided by operating activities	265,584	200,304
Cash flows from investing activities:
Purchases of property, plant and equipment	(106,062)	(67,141)
Acquisitions of businesses, net of cash acquired, and other	(9,235)	(144,969)
Insurance proceeds received	1,254	6,624
Proceeds from sale of marketable securities	238	0
Net cash used in investing activities	(113,805)	(205,486)
Cash flows from financing activities:
Proceeds from long-term debt	975,000	1,152,575
Repayments of long-term debt	(1,108,034)	(1,038,427)
Net proceeds from (repayments of) short-term debt	8,380	(63,057)
Repurchase of common stock	(44,363)	(71,150)
Proceeds from issuance of common stock for employee stock plans	19,094	27,160
Excess tax benefit from share-based compensation awards	15,700	10,760
Purchase of Origio shares from noncontrolling interests	(2,641)	0
Dividends on common stock	(1,449)	(1,421)
Debt acquisition costs	0	(1,317)
Distributions to noncontrolling interests	(1,007)	0
Payment of contingent consideration	(3,600)	(1,314)
Proceeds from construction allowance	4,781	0
Net cash (used in) provided by financing activities	(138,139)	13,809
Effect of exchange rate changes on cash and cash equivalents	(998)	(1,070)
Net increase in cash and cash equivalents	12,642	7,557
Cash and cash equivalents - beginning of period	12,840	5,175
Cash and cash equivalents - end of period	$ 25,482	$ 12,732